Karl Dobianer

DNA Amplification of HER-2/neu and INT-2 Oncogenes in Epithelial Ovarian Cancer

M. Medl, P. Sevelda, K. Czerwenka et al. · Gynecologic Oncology · 1995 · 43 citations

Medicine, Molecular Biology, Oncology +16

First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer

Anders Rosén, P. Sevelda, Michael Klein et al. · British Journal of Cancer · 1993 · 30 citations · Full text

Medicine, Gynecology, Oncology +12

HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples

Christa Hruza, Karl Dobianer, A. Beck et al. · European Journal of Cancer · 1993 · 26 citations

Medicine, Oncology, Pathology +14

Cystic fibrosis screening in neonates — measurement of immunoreactive trypsin and direct genotype analysis for ΔF508 mutation

JWA Larsen, Sanchika Campbell, E. Brian Faragher et al. · European Journal of Pediatrics · 1994 · 21 citations

Medicine, Genetics, Molecular Genetics +17

HER-2 Oncogene Is Not Amplified in Primary Carcinoma of the Fallopian Tube

Markus Stühlinger, A.C. Rosen, Karl Dobianer et al. · Oncology · 2009 · 11 citations

Medicine, Oncology, Pathology +16